Patients are no longer passive healthcare consumers, due in part to the Internet and an increased interest in and media attention to healthcare. Medscape Medical News
As first-line therapy for metastatic breast cancer, nab-paclitaxel (Abraxane), a solvent-free formulation of the drug, significantly improves progression-free survival compared with use of docetaxel, researchers report in the Journal of Clinical Oncology for May 26. Reuters Health Information
Phase 2 results from a randomized controlled trial show very early mobilization of stroke patients within 24 hours of symptom onset significantly reduces rates of depression in this population. Medscape Medical News